# US 2019/0316106 A1 · Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316106 A1
- Document ID: US20190316106A1
- Status: Published application
- Kind: A1
- Application number: 16/429,529
- Filed: 2019-06-03
- Published: 2019-10-17
- Earliest claimed: 2012-10-24
- Assignees: Novozymes A/S; Novozymes, Inc.
- Applicants: Novozymes A/S; Novozymes, Inc.
- Inventors: Nikolaj Spodsberg; Tarana Shaghasi; Matt Sweeney; Feng Xu; Kirk Schnorr
- Web page: https://patentgrep.com/patent/US20190316106A1

## CPC

- C12N 9/2437: {Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)}
- C12N 15/8246: {Non-starch polysaccharides, e.g. cellulose, fructans, levans}
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A nucleic acid construct, comprising a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the GH61 polypeptide in a recombinant host cell, and wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from the group consisting of:
(a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 8;
(b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the mature polypeptide coding sequence of SEQ ID NO: 7 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 7, wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, for 12 to 24 hours, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C.; and
(c) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 7 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 7.

### Claim 22 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 23 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 24 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 25 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 26 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 27 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide comprises SEQ ID NO: 8 or the mature polypeptide of SEQ ID NO: 8.

### Claim 28 (depends on 21)

The nucleic acid construct of claim 21, wherein the GH61 polypeptide comprises amino acids 17 to 322 of SEQ ID NO: 8.

### Claim 29 (depends on 21)

A recombinant host cell transformed with the nucleic acid construct of claim 21.

### Claim 30 (depends on 29)

A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: (a) cultivating the recombinant host cell of claim 29 under conditions conducive for production of the polypeptide, and optionally (b) recovering the polypeptide.

### Claim 31

A recombinant host cell, transformed with a nucleic acid construct comprising a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polynucleotide is operably linked to one or more control sequences that direct the production of the GH61 polypeptide in the recombinant host cell, wherein the GH61 polypeptide having cellulolytic enhancing activity is heterologous to the recombinant host cell, and wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from the group consisting of:
(a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 8;
(b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the mature polypeptide coding sequence of SEQ ID NO: 7 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 7, wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, for 12 to 24 hours, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C.; and
(c) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 7 or the cDNA sequence of the mature polypeptide coding sequence of SEQ ID NO: 7.

### Claim 32 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 33 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 34 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 35 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 36 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 8.

### Claim 37 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide comprises SEQ ID NO: 8 or the mature polypeptide of SEQ ID NO: 8.

### Claim 38 (depends on 31)

The recombinant host cell of claim 31, wherein the GH61 polypeptide comprises amino acids 17 to 322 of SEQ ID NO: 8.

### Claim 39 (depends on 31)

A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: (a) cultivating the recombinant host cell of claim 31 under conditions conducive for production of the polypeptide, and optionally (b) recovering the polypeptide.

### Claim 40 (depends on 21)

A transgenic plant, plant part or plant cell transformed with the nucleic acid construct of claim 21.

### Claim 41 (depends on 40)

A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising: (a) cultivating the transgenic plant or plant cell of claim 40 under conditions conducive for production of the polypeptide, and optionally (b) recovering the polypeptide.
